Rite Aid Will Keep Selling Oral Phenylephrine Despite FDA Panel Doubts; CVS To Remove Products
-
Rite Aid will keep selling medications with phenylephrine despite FDA panel finding ingredient ineffective when taken orally. Rite Aid will comply if FDA ultimately decides to remove the products.
-
CVS has said it will remove oral medications containing phenylephrine as the only active ingredient from its stores.
-
Walgreens is deferring to federal regulators and has not made a decision yet on removing oral phenylephrine products.
-
FDA advisory committee voted that scientific data does not support phenylephrine as an effective oral nasal decongestant.
-
Group representing OTC drug makers opposes any regulatory changes, citing evidence supporting phenylephrine and negative consequences of removing it.